Sponsor or institution
Clinical trials and research at Neurogt, INC.
As of November 12, 2026, Find a Trial lists 6 NIH-funded research projects at this institution, with $5.9 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6NIH research projects
NIH-funded research (6)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Trans-BBB AAV9 gene therapy for CNS symptoms in kids with MPS I
A gene therapy designed to get an IDUA enzyme into the brain to help children with MPS I who have brain-related problems.
-
AAV gene therapy for treating MPS IIIB in children
A small, fast-track NIH grant is funding a pediatric gene therapy approach to treat MPS IIIB using an AAV9 vector to deliver the NAGLU enzyme.
-
AAV gene therapy to treat MPS IIIC neuropathy
A specialized gene therapy using an AAV9 vector is being developed to address the brain and nerve damage in people with MPS IIIC.
-
Gene therapy for Sanfilippo syndrome type B (MPS IIIB)
This project aims to deliver an AAV9 gene therapy that replaces the missing NAGLU enzyme for children with MPS IIIB (Sanfilippo B).
-
Removing antibodies that block AAV gene therapy
A short-acting IV treatment that temporarily removes antibodies that stop AAV-based gene therapies so more people can get these treatments.
-
Developing a gene therapy to treat MPS IIIB in children
This study is working on a new gene therapy to help children with Mucopolysaccharidosis IIIB (MPS IIIB) by using a special virus to deliver a corrected gene that can help produce an important enzyme they are missing, with the hope of making them feel better and reducing the effects of the disease.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.